Company: VRCA
Filing Date: 2025-12-15
Form Type: S-3
Source: 0001193125-25-319225
Chunk: 26

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-12-15
Form: S-3
Chunk 26
---
S BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Jayson Rieger, John J. Kirby and David Zawitz, jointly and severally, as his or her true and lawful agent, proxy and attorneys-in-fact,with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to (i) act on, sign and file with the Securities and Exchange Commission any and all amendments (including post-effective amendments) to this registration statement together with all schedules and exhibits thereto and any subsequent registration statement filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended, together with all schedules and exhibits thereto, (ii) act on, sign and file such certificates, instruments, agreements and other documents as may be necessary or appropriate in connection therewith, (iii) act on and file any supplement to any prospectus included in this registration statement or any such amendment or any subsequent registration statement filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended, and (iv) take any and all actions which may be necessary or appropriate to be done, as fully for all intents and purposes as he or she might or could do in person, hereby approving, ratifying and confirming all that such agent, proxy and attorney-in-factor any of his or her substitutes may lawfully do or cause to be done by virtue thereof. Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

| Signature         
 /s/ Jayson Rieger 
 Jayson Rieger     
 /s/ John J. Kirby 
 John J. Kirby     |     | Title                                                                          
 Chief Executive Officer and Director (Principal Executive Officer)             
 Interim Chief Financial Officer                                                
 (Interim Principal Financial Officer and Interim Principal Accounting Officer) |     | Date              
 December 15, 2025 
 December 15, 2025 |
|:------------------|:----|:-------------------------------------------------------------------------------|:----|:------------------|
| /s/ Paul Manning  
 Paul Manning      |     | Chairman of the Board of Directors                                             |     | December 15, 2025 |
| /s/ Diem Nguyen   
 Diem Nguyen       |     | Director                                                                       |     | December 15, 2025 |
| /s/ Mark Prygocki